Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
How to Find a Cancer Treatment Trial
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
Featured Clinical Trials Supported by NCI
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Cancer Type/Condition:
Brain tumor, child: Astrocytoma/Astrocytic tumors
Stage/Subtype:
untreated childhood cerebellar astrocytoma
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Any age
Sponsor:
Other
Protocol IDs:
05-122
, MSKCC-05122, NCT00445965
2.
Valproic Acid and Radiation Followed by Maintenance Valproic Acid and Bevacizumab in Children With High Grade Gliomas
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
3 to 21
Sponsor:
Other
Protocol IDs:
24549
, NCT00879437
3.
Antineoplaston Therapy in Treating Children With Brain Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
6 months to 17 years
Sponsor:
Other
Protocol IDs:
CDR0000066490
, BC-BT-10, NCT00003458
4.
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
3 to 22
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
07-098
, NCT00634231
5.
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 months to 23 years
Sponsor:
Other
Protocol IDs:
ACH-CNS-001
, NCT00876993
6.
Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
Phase:
No phase specified
Type:
Natural history/Epidemiology, Treatment
Status:
Active
Age:
2 to 25
Sponsor:
Other
Protocol IDs:
2005P001629
, NCT01115777
Select All on Page
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Follow Us:
Twitter
YouTube
Facebook
RSS
Other Versions:
Mobile
|
Español
U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
USA.gov
NIH…Turning Discovery Into Health
®